391 related articles for article (PubMed ID: 26611146)
1. Identification and analysis of divergent immune gene families within the Tasmanian devil genome.
Morris KM; Cheng Y; Warren W; Papenfuss AT; Belov K
BMC Genomics; 2015 Nov; 16():1017. PubMed ID: 26611146
[TBL] [Abstract][Full Text] [Related]
2. Lack of genetic diversity across diverse immune genes in an endangered mammal, the Tasmanian devil (Sarcophilus harrisii).
Morris KM; Wright B; Grueber CE; Hogg C; Belov K
Mol Ecol; 2015 Aug; 24(15):3860-72. PubMed ID: 26119928
[TBL] [Abstract][Full Text] [Related]
3. Characterization of antibody V segment diversity in the Tasmanian devil (Sarcophilus harrisii).
Ujvari B; Belov K
Vet Immunol Immunopathol; 2015 Oct; 167(3-4):156-65. PubMed ID: 26300316
[TBL] [Abstract][Full Text] [Related]
4. Heat shock proteins expressed in the marsupial Tasmanian devil are potential antigenic candidates in a vaccine against devil facial tumour disease.
Tovar C; Patchett AL; Kim V; Wilson R; Darby J; Lyons AB; Woods GM
PLoS One; 2018; 13(4):e0196469. PubMed ID: 29702669
[TBL] [Abstract][Full Text] [Related]
5. Evolutionary histories of transposable elements in the genome of the largest living marsupial carnivore, the Tasmanian devil.
Gallus S; Hallström BM; Kumar V; Dodt WG; Janke A; Schumann GG; Nilsson MA
Mol Biol Evol; 2015 May; 32(5):1268-83. PubMed ID: 25633377
[TBL] [Abstract][Full Text] [Related]
6. Identification of natural killer cell receptor genes in the genome of the marsupial Tasmanian devil (Sarcophilus harrisii).
van der Kraan LE; Wong ES; Lo N; Ujvari B; Belov K
Immunogenetics; 2013 Jan; 65(1):25-35. PubMed ID: 23007952
[TBL] [Abstract][Full Text] [Related]
7. Diversity in the Toll-like receptor genes of the Tasmanian devil (Sarcophilus harrisii).
Cui J; Cheng Y; Belov K
Immunogenetics; 2015 Mar; 67(3):195-201. PubMed ID: 25563844
[TBL] [Abstract][Full Text] [Related]
8. Evidence for induction of humoral and cytotoxic immune responses against devil facial tumor disease cells in Tasmanian devils (Sarcophilus harrisii) immunized with killed cell preparations.
Kreiss A; Brown GK; Tovar C; Lyons AB; Woods GM
Vaccine; 2015 Jun; 33(26):3016-25. PubMed ID: 25708088
[TBL] [Abstract][Full Text] [Related]
9. Cancer- and behavior-related genes are targeted by selection in the Tasmanian devil (Sarcophilus harrisii).
Hubert JN; Zerjal T; Hospital F
PLoS One; 2018; 13(8):e0201838. PubMed ID: 30102725
[TBL] [Abstract][Full Text] [Related]
10. Evolution in a transmissible cancer: a study of the chromosomal changes in devil facial tumor (DFT) as it spreads through the wild Tasmanian devil population.
Pearse AM; Swift K; Hodson P; Hua B; McCallum H; Pyecroft S; Taylor R; Eldridge MD; Belov K
Cancer Genet; 2012 Mar; 205(3):101-12. PubMed ID: 22469509
[TBL] [Abstract][Full Text] [Related]
11. Antigen-presenting genes and genomic copy number variations in the Tasmanian devil MHC.
Cheng Y; Stuart A; Morris K; Taylor R; Siddle H; Deakin J; Jones M; Amemiya CT; Belov K
BMC Genomics; 2012 Mar; 13():87. PubMed ID: 22404855
[TBL] [Abstract][Full Text] [Related]
12. Development of a SNP-based assay for measuring genetic diversity in the Tasmanian devil insurance population.
Wright B; Morris K; Grueber CE; Willet CE; Gooley R; Hogg CJ; O'Meally D; Hamede R; Jones M; Wade C; Belov K
BMC Genomics; 2015 Oct; 16():791. PubMed ID: 26467759
[TBL] [Abstract][Full Text] [Related]
13. Characterization of major histocompatibility complex class I and class II genes from the Tasmanian devil (Sarcophilus harrisii).
Siddle HV; Sanderson C; Belov K
Immunogenetics; 2007 Sep; 59(9):753-60. PubMed ID: 17673996
[TBL] [Abstract][Full Text] [Related]
14. Devil Facial Tumor Disease.
Pye RJ; Woods GM; Kreiss A
Vet Pathol; 2016 Jul; 53(4):726-36. PubMed ID: 26657222
[TBL] [Abstract][Full Text] [Related]
15. Genetic diversity and population structure of the endangered marsupial Sarcophilus harrisii (Tasmanian devil).
Miller W; Hayes VM; Ratan A; Petersen DC; Wittekindt NE; Miller J; Walenz B; Knight J; Qi J; Zhao F; Wang Q; Bedoya-Reina OC; Katiyar N; Tomsho LP; Kasson LM; Hardie RA; Woodbridge P; Tindall EA; Bertelsen MF; Dixon D; Pyecroft S; Helgen KM; Lesk AM; Pringle TH; Patterson N; Zhang Y; Kreiss A; Woods GM; Jones ME; Schuster SC
Proc Natl Acad Sci U S A; 2011 Jul; 108(30):12348-53. PubMed ID: 21709235
[TBL] [Abstract][Full Text] [Related]
16. Genome sequencing and analysis of the Tasmanian devil and its transmissible cancer.
Murchison EP; Schulz-Trieglaff OB; Ning Z; Alexandrov LB; Bauer MJ; Fu B; Hims M; Ding Z; Ivakhno S; Stewart C; Ng BL; Wong W; Aken B; White S; Alsop A; Becq J; Bignell GR; Cheetham RK; Cheng W; Connor TR; Cox AJ; Feng ZP; Gu Y; Grocock RJ; Harris SR; Khrebtukova I; Kingsbury Z; Kowarsky M; Kreiss A; Luo S; Marshall J; McBride DJ; Murray L; Pearse AM; Raine K; Rasolonjatovo I; Shaw R; Tedder P; Tregidgo C; Vilella AJ; Wedge DC; Woods GM; Gormley N; Humphray S; Schroth G; Smith G; Hall K; Searle SM; Carter NP; Papenfuss AT; Futreal PA; Campbell PJ; Yang F; Bentley DR; Evers DJ; Stratton MR
Cell; 2012 Feb; 148(4):780-91. PubMed ID: 22341448
[TBL] [Abstract][Full Text] [Related]
17. Curse of the devil: molecular insights into the emergence of transmissible cancers in the Tasmanian devil (Sarcophilus harrisii).
Patchett AL; Flies AS; Lyons AB; Woods GM
Cell Mol Life Sci; 2020 Jul; 77(13):2507-2525. PubMed ID: 31900624
[TBL] [Abstract][Full Text] [Related]
18. Demonstration of immune responses against devil facial tumour disease in wild Tasmanian devils.
Pye R; Hamede R; Siddle HV; Caldwell A; Knowles GW; Swift K; Kreiss A; Jones ME; Lyons AB; Woods GM
Biol Lett; 2016 Oct; 12(10):. PubMed ID: 28120799
[TBL] [Abstract][Full Text] [Related]
19. Tasmanian devil cathelicidins exhibit anticancer activity against Devil Facial Tumour Disease (DFTD) cells.
Petrohilos C; Patchett A; Hogg CJ; Belov K; Peel E
Sci Rep; 2023 Aug; 13(1):12698. PubMed ID: 37542170
[TBL] [Abstract][Full Text] [Related]
20. Doxorubicin and carboplatin trials in Tasmanian devils (Sarcophilus harrisii) with Tasmanian devil facial tumor disease.
Phalen DN; Frimberger AE; Peck S; Pyecroft S; Harmsen C; Lola S; Moore AS
Vet J; 2015 Dec; 206(3):312-6. PubMed ID: 26538144
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
